secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2026-02-18T23:59:59+00:00
Accession:  0001193125-26-057393
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Iterum shareholders reject all four EGM proposals; company warns of possible wind-down
--------------------------------------------------------------------------------

- Shareholders voted against increasing authorized share capital (12.8M for vs 17.9M against).
- Reverse share split proposal also defeated: 13.9M for vs 16.7M against.
- Directors' allotment authority and pre-emption opt-out similarly rejected.
- Company says vote results restrict ability to raise capital, harming operations and going concern.
- Management warns of possible wind-down, bankruptcy, or liquidation; shareholders unlikely to receive distribution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000119312526057393/0001193125-26-057393-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000119312526057393/itrm-20260218.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-057393

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer